Our associates in Europe and Asia specialize in increasing access to medical devices and services. Our ability to provide actionable, result-oriented strategies based upon the systematic and reproducible analysis of up-to-date local market intelligence helps us assist and inform stake holder decision making in all sectors global healthcare community.
April 2019 - August 2019
Support to develop and implement PoC pre-eclampsia and Sickle Cell Diseases Market Access Strategy to Africa
February 2019 - Ongoing
Support to promote the introduction of PoC HCV assays in LMICs
November/December 2018
Commercial and go-to-market strategy evaluations of 3 companies to be funded up to $2m to develop HCV RNA assay at PoC level in LMICs
October/November 2018
Market research to provide a situation analysis regarding the readiness and way forward to the commercialization of Clinical Decision Support (CDS) tools associated to diagnostic tests performed in LMICs
August/December 2018
Support to UN agency to develop a business case for the development of Quality Control Material intended for end-users of IVD Medical Devices in LMICs
July – December 2018
Support the International AIDS Society’s Industry Liaison Forum meeting at AIDS 2018 and coordinate the production of a publication devoted to aspects of new technology adoption’s challenge and barriers
June - July 2018
PoC Haematology Market research to provide a situation analysis of commercialized haematology solutions that could be used at Point of Care or Near to Patient levels as well as identify promising technologies that could be developed and commercialized within the next 5 years in low and middle-income countries
June 2018
Market research and Product development recommendation for strategic investment group seeking to better understand LFA opportunity in LMICs
May - October 2018
Health-related financial flow market research in sSA and EECA countries to provide guidance, to a Dx client, regarding national and international financial resources from 14 donating countries to support commercial growth strategies
February - March 2018
Situation Analysis on Viral Hepatitis Dx Capability in Africa to collect and consolidate information regarding the capacity for African countries to screen, diagnose and monitor viral hepatitis programs. A secondary objective is to provide guidance to our pharmaceutical client to develop innovative strategies with MoHs and Dx industry
July - September 2017
Kenya Healthcare System and Stakeholder mapping to collect and consolidate information regarding the healthcare system and stakeholders to provide guidance to Dx client concerning collaboration with MoH and key other public/private sectors actors
June 2017 - January 2018
Advisory support to a Dx client launching HCV Viral Load at Point of Care testing level
May 2017
Support to provide guidance regarding the Malaria RDT Outlook for the 2017-2022 period in the context of the malaria elimination strategy set by the WHO
April - May 2017
Early Infant Diagnosis & Treatment - Market Research to collect and consolidate information regarding the market dynamic in key focus African countries and the readiness for Ministry of Health to implement innovative PoC solutions
March 2017
Support to provide guidance to a Dx company regarding market readiness to HCV PoC MDx solution
September 2016 - January 2017
Support Dx company to collect and consolidate information concerning the current state of Hepatitis C programs in SSA, EU5 and MENA regions in response to 2016 EASL and WHO new care & treatment recommendations. A secondary objective was to identify additional/optional opportunities to grow HCV business, strengthen customer commitments and create new sales revenue
July 2016
HIV and HCV Drug – Resistance Market Research to provide guidance to a French based RBO regarding the business opportunity to develop new resistance assays targeting Sub-Saharan Africa and SE-Asia markets
May 2016
Market readiness evaluation – through in-country visit - in PNG (Papua New-Guinea) for an USG implementer to establish a private (or public-private mix) laboratory to help address the country deficiencies and needs
December 2015 to March 2016 then June to September 2016
Private Sector Engagement advisory support to a non-for-profit organization working to advocate the critical role and needs of high-quality laboratory medicine and networks throughout Africa
November 2015 to January 2017
Support to a Canadian life science product development firm with primary focus to develop “Go to Market” strategy including – but not limited to - the development of business plans, fundraising strategies, market assessments, policy/regulatory landscape and necessary collaborations at global and country levels